Form 4 for EYPT EyePoint, Inc.
Accepted 2024-01-16 00:00:00 ET · period of report 2024-01-11 · accession 0001840315-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-16 | 2024-01-11 | EYPT | Ocumension Therapeutics | Dir | S - Sale | $19.45 | -1.91M | 100.2K | -95% | -$37.16M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common stock | 2024-01-11 | S | D | 1,910,500 | $19.45 | 100,221 | D | — | — | (F1) T+2 settlement on Jan 16 |